MARY ANN GRAY Insider Trading $DYAX DYAX CORP
Get free email notifications about insider trading for MARY ANN GRAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARY ANN GRAY. MARY ANN GRAY is Director in JUNIPER PHARMACEUTICALS INC ($JNP) and Director in Sarepta Therapeutics, Inc. ($SRPT) and in DYAX CORP ($DYAX) and Director in DYAX CORP ($DYAX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SENOMYX INC ($SNMX) and Director in Seneca Biopharma, Inc. ($SNCA) and Director in Galena Biopharma, Inc. ($GALE) and Director in Keros Therapeutics, Inc. ($KROS) and in RAPT Therapeutics, Inc. ($RAPT) and Director in RAPT Therapeutics, Inc. ($RAPT).
MARY ANN GRAY in DYAX CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of MARY ANN GRAY:
Holdings: 0 shares
Latest Transaction: Jan 22 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARY ANN GRAY in DYAX CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, DYAX, JNP, KROS, MBVX, SNCA, RAPT, SRPT, SLS, SNMX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Option Exercise | D | 26.23 | 16,667 | 437,175 | 0 | ||
| Jan 22 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Sell | D | 0.00 | 232,440 | 0 | 0 | 232.4 K to 0 (-100.00 %) | |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 26.23 | 33,333 | 874,325 | 16,667 | |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 6.17 | 25,000 | 154,250 | 0 | |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 2.06 | 8,107 | 16,700 | 0 | |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 2.09 | 75,000 | 156,750 | 0 | |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 3.82 | 75,000 | 286,500 | 0 | |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | M | 2.97 | 6,000 | 17,820 | 0 | |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 26.23 | 33,333 | 874,325 | 232,440 | 199.1 K to 232.4 K (+16.74 %) |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 6.17 | 25,000 | 154,250 | 199,107 | 174.1 K to 199.1 K (+14.36 %) |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 2.06 | 8,107 | 16,700 | 174,107 | 166 K to 174.1 K (+4.88 %) |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 2.09 | 75,000 | 156,750 | 166,000 | 91 K to 166 K (+82.42 %) |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 3.82 | 75,000 | 286,500 | 91,000 | 16 K to 91 K (+468.75 %) |
| Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | M | 2.97 | 6,000 | 17,820 | 16,000 | 10 K to 16 K (+60.00 %) |
| May 14 2015 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | A | 26.23 | 50,000 | 1,311,500 | 50,000 |
Page: 1